Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
Published: February 6, 2023
3rd February 2023 – Imogen Fitt – Featured on hitconsultant.net
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.
Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights service, below we outline the wider investment landscape and our own views on what the future holds below.
Click here to read the full article.
Share on LinkedInRelated Report
Digital Pathology
Published April 2023Digital Pathology
This is a brochure for Signify Research’s 2023 report on the global market for Digital Pathology published April 2023.
Find out more
Related Report
Digital Pathology Market Intelligence Service
Ongoing series of reports delivered over the yearDigital Pathology Market Intelligence Service
This Market Intelligence Service provides a rolling 12-month coverage of the global Digital Pathology market.
Find out more